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Abstract. We are interested in the mean-field evolution of a growing tumor as it emerges from
a stochastic agent-based multiscale model. To this end, we introduce a hybrid PDE/Monte Carlo
variance reduction technique. The variance reduction on the cell densities is achieved by combining a
simulation of the stochastic agent-based model on the microscopic scale with a deterministic solution
of a simplified (coarse) partial differential equation (PDE) on the macroscopic scale as a control
variable. We show that this technique is able to significantly reduce the variance with only the
(limited) additional computational cost associated with the deterministic solution of the coarse PDE.
We illustrate the performance with numerical experiments in different biological scenarios.
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1. Introduction. Tumor growth is a complex biological phenomenon consisting
of processes on different scales. On the cellular level – which will be referred to as the
microscopic scale in this paper – one has to track the random motion of cells, as well
as the cell division and cell death. The latter are governed by numerous intracellular
processes. Furthermore, the cellular behavior is strongly coupled to the environment
and vice versa. For example, local oxygen concentration and the local cell density
are major contributors to the cell proliferation while hypoxia can trigger apoptosis.
On the other hand, cells also consume oxygen [44, 26, 63]. This two-way feedback
creates very specific dynamics characterizing the development of a tumor. A hypoxic
zone develops in the middle of the tumor, which in turn triggers endothelial cells to
vascularize the tumor. This process, also known as angiogenesis [11], ensures that
the tumor’s need for oxygen and other nutrients is satisfied, which facilitates further
growth of the tumor.
Smaller avascular tumors can be easily simulated on the microscopic scale using agent-
based models [37, 42, 4, 54, 61, 46]. We can distinguish two classes of models. On the
one hand, cellular automata update grid cells based on a number of phenomenological
rules, while on the other hand lattice-free models mainly consist of a set of ordinary
differential equations (ODEs) attached to each cell.
On long time scales, we are mainly interested in the tumor as a whole, which we
call the macroscopic scale. Agent-based models are typically not well suited to use
on larger scales, since the individual based character implies a large computational
cost for a large number of particles, corresponding to larger tumors. One may choose
to model the system directly on this scale using continuum models, based on mass
balance equations [8, 50, 66, 58, 57, 34]. We refer to [18, 59, 3] for a description of the
use of such mean-field approaches to model large (biological) complex systems. While
a mean-field approach results in significantly cheaper simulations than agent-based
models, which are moreover easier to analyze, it cannot capture discrete features as
branching of a vascular network or events regulated by intracellular concentrations.
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Instead, the effects of such phenomena need to be modeled indirectly at the contin-
uum scale, using approximate closure relations that describe the dynamics directly at
the continuum level. For instance, a mean-field partial differential equation (PDE)
that describes tumor density as a function of space and time needs to contain a re-
action term that describes the increase in the number of tumor cells as a function of
the tumor density, while tumor growth in reality arises due to complex intracellular
dynamics that regulates the cell cycle.
The complementary requirements of a fast simulation method and sufficient modeling
detail gave rise to multiscale models where agent-based models are typically used to
model the cellular component, while the environment is mostly described by a set
of reaction-diffusion partial differential equations, corresponding to the macroscopic
scale. Examples can be found in [22, 44, 17, 30, 5, 43]. For a review about the current
state of the art in multiscale modeling of tumor growth, we refer to [19, 48, 64, 13, 49].
A computational drawback of such agent-based models for the study of the mean-field
behavior of tumor growth is their sensitivity to noise due to the random motion of the
cells, which influences their interaction with the environment. When simulating with
a standard Monte Carlo algorithm, the variance depends on the number of simulated
cells. Various techniques for variance reduction such as antithetic variables, control
variates and importance sampling are described in literature, see e.g. [9, 38] for an
overview. Recently, several hybrid PDE/Monte Carlo algorithms have been proposed
in the literature to achieve variance reduction by coupling a PDE-based discretiza-
tion to a Monte Carlo simulation [20, 51, 47]. It is such a hybrid PDE/Monte Carlo
method that we propose here for tumor growth.
In this paper, we aim at modeling mean-field behavior as accurately as possible for a
reasonable computational cost, without explicitly deriving a closed form of the evolu-
tion on the macroscopic scale. Instead, we want to directly incorporate the influence
of agent-based features on the mean-field level, which are not incorporated usually
in mean field approximations. We start from a multiscale model that combines an
agent-based description of the cells with a PDE-based description of the environ-
ment. However, we also introduce an approximate, mean-field PDE-based description
of advection-diffusion type for the cellular component. This “coarse” approximation
only accounts for the motion of the cells; no cell division of apoptosis is present at
this level. However, the advection-diffusion behavior of the cells can be simulated
deterministically with this model (thus without noise). This deterministic simulation
is then augmented with the reaction term, which is computed directly from an agent-
based simulation, without any closure approximation.
The contributions of this paper are two-fold:
• We develop a multiscale model where the random motion is modeled using
stochastic differential equations (SDEs), the intracellular variables for the cell
cycle and apoptosis are described by ODEs and the environment, consisting of
diffusible components, is modeled by PDEs. The model is a modified version
of the cellular automaton model of Owen et al. [44]. The main differences
are that the new model is lattice-free and the fact that our model does not
contain any explicit delay terms.
• We propose a novel technique to reduce the variance on the cellular densities
obtained via an adapted multiscale agent-based model. Based on the ideas
in [51, 20], we develop a hybrid PDE/Monte Carlo method using a coarse
stochastic process (called the control process) and a corresponding PDE. In
this specific case, the control process modeling the spatial behavior of the
individual cells contains all details of the microscopic model except for cell
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births, cell deaths and VEGF (denoting Vascular Endothelial Growth Factor)
secretion. The key point is to obtain this missing information with reduced
variance by an appropriate coupling between the full microscopic agent-based
model and the control process.
We first give a detailed overview of the different layers of the model in section 2.
Next, we describe the variance reduction algorithm in the section 3. We illustrate
the technique numerically in section 4. Finally, in section 5 we elaborate on a few
possibilities for future research.
ABM:
• Position x
• Cell cycle phase φ
• Apoptosis variable z
• [p53]
• [VEGF]int
Environment:
• Oxygen [O2]
• VEGF
• Vascular network
Coarse description:
• Cellular densities
np(x, t)
Fig. 1. Overview variables and interactions. Dashed lines indicates oxygen consumption; dotted
lines denote VEGF production; the solid line denotes the fact that the density consists of cells.
2. Models. In this section, we describe a multiscale model for tumor growth.
The microscopic model for tumor growth is based on the ideas used to describe bac-
terial chemotaxis [21, 51], the multiscale cellular automaton model was developed
by Owen and coworkers [44]. Our goal is to perform variance reduction in order to
estimate the resulting population densities in a more accurate way. As in [51], the
model proposed in this paper is time and space continuous. Apart from that the
model is lattice-free, making the computational cost quasi independent of the size of
the domain and hence, we can easily rescale the system to simulate larger tumors
(compared to the examples given in [44]).
We distinguish two main components: the environment, modeled by a couple of reac-
tion diffusion equations and the agent-based model describing the individual cellular
motion and internal variables (e.g., cell cycle, apoptosis state and internal concentra-
tions such as VEGF and the intracellular level of the tumor suppressor gene p53 [44])
attached to each cell.
We consider P types of cells, indexed by p = {1, 2, . . . , P}. In this paper, we choose
P = 3, corresponding to normal cells (p = 1), cancer cells (p = 2), and endothelial
cells (that build up blood vessels, p = 3). For each of these cell types, we consider an
ensemble of Ip(t) cells, and consider three state variables: position x ∈ R
2, cell cycle
phase φ ∈ [0, 1]. The intracellular concentrations [VEGF]int, [p53] and apoptosis vari-
able z are scalars ∈ R. These cells evolve according to evolution laws that depend on
the concentration [O2](x, t) of oxygen and [VEGF](x, t) of the Vascular Endothelial
Growth Factor (which we call the environment).
Note that the reaction-diffusion partial differential equations (PDEs) describing the
diffusible components of the environment still need to be solved on a grid, but this
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cost is marginal due to the sparsity of the involved linear systems, which ensures that
the cost dependent on the domain size is limited.
We now give an overview of the notations that will be used throughout the paper,
after which we describe the evolution laws for the environment, and detail the evolu-
tion laws for each of the cell types. The cell type dependency is mainly caused by cell
type dependent coefficients, which will be discussed later on in the section describing
the agent-based model in more detail.
Notation.
• Note that in general we use lower case letters for general variables and upper
case letters to denote the actual value of a certain variable attached to a
specific particle.
• The state variables attached to a single cell of type p at time t are position
Xp(t), printed in bold to stress that we are dealing with a vector in this
paper. The position variable x actually consists of two components (x and
y). Further, cell cycle phase Φp(t), generation ζp(t), internal concentrations
[p53]p(t), [VEGFint]p(t) and apoptosis variable Zp(t).
• Cell number densities are denoted by np(x, t) indexed by a suitable subscript
to indicate the nature of the density. Further, nv(x, t) is used to describe the
vascular density.
• To keep a consistent notation throughout the paper, we introduce the follow-
ing convention. If, at a moment t = t⋆, the cell with index i⋆ in population p
divides, we set
(1) Ip(t
⋆) = Ip(t
⋆
−) + 1
in which the symbol t⋆− is used to emphasize that the involved number of cells
is meant to be taken just before the division. Simultaneously, we introduce a
new cell. When a cell undergoes apoptosis, it is removed from the simulation.
To avoid cumbersome renumbering of the cells in the text, we associate a
weight wi,p(t) to each of the cells. If the cell is alive, the corresponding
weight is one; upon apoptosis, it becomes zero. The active number of cells is
therefore:
(2) I¯p(t) =
Ip(t)∑
i=1
wi,p(t).
• The evolution of the state variables is influenced in various ways by the (local)
environment. The latter will be modeled by means of diffusible components
[VEGF](x, t) describing the VEGF concentration, while [O2](x, t) denotes the
oxygen concentration.
• Throughout the text, we use multiple field quantities that depend on space
and time, such as n(x, t) and [O2](x, t). We will often need the values of
these fields at particular particle position. Suppose that f is a generic field
quantity of this type, then f(Xp(t), t) represents the value of f at the grid
cell location corresponding to Xp(t) at time t.
2.1. Agent-based model. In this section, we give a detailed overview of the
evolution of the different state variables attached to each cell of the different cellular
populations. Note that there are multiple modeling strategies possible for each part
of the agent-based model. For both cell division and apoptosis, we start from the
intracellular model of Owen [44].
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Position. The random motion of the position of the cells is described as a biased
Brownian motion which is modeled via a stochastic differential equation (SDE) con-
sisting of two parts: a random and a deterministic part. The infinitesimal change in
position is denoted by dXp. Cells of type p move randomly with diffusion coefficient
Dp, modeled via a standard Brownian motion with Brownian increments dWt, and
are chemotactically attracted towards high VEGF concentrations with sensitivity χp.
This sensitivity is only important for the endothelial cells, responsible for blood vessel
growth,
(3) dXp(t) = χp∇[VEGF](Xp(t), t))
(
1−
np(Xp(t), t)
nmax,p
)
dt︸ ︷︷ ︸
Directed motion
+
√
2DpdWt︸ ︷︷ ︸
Random motion
.
in which the cell number density can be represented as:
(4) np(x, t) =
Ip(t)∑
i=1
wi,p(t)δXi,p(t),
where Ip(t) denotes the total number of cells of type p at time t and δXi,p(t) is defined
as follows:
(5) δXi,p(t) =
{
1 Xi,p(t) ∈ grid cell x,
0 otherwise.
Note that, in contrast to the cellular automaton model with discrete space jumps
described in [44], the resulting equation for the position is a stochastic differential
equation (SDE). Finally, we stress that the above equation is general for all the cell
types and differences between cell types are induced by specific choices of parameters.
For instance, normal cells don’t move at all, while cancer cells are characterized by
pure diffusive motion and endothelial cells demonstrate diffusive behavior while also
responding to chemotactic cues.
Cell division. This process is modeled by means of the following ODE:
(6)
dΦp(t)
dt
=
[O2](Xp(t), t)
τmin,p(Cφ,p + [O2](Xp(t), t))︸ ︷︷ ︸
Cell cycle speed on local oxygen concentration
× H(ζp,max − ζp(t))︸ ︷︷ ︸
Restriction depending on generation
,
where τmin,p denotes the minimal time needed for a cell to complete one cell cycle, H
defines the classical Heaviside function and hence we have the following equation:
(7) H(ζp,max − ζp(t)) =
{
1 if ζp(t) ≤ ζp,max,
0 otherwise,
and ζ indicates the generation of a cell. Note that τmin,p depends on the cell type. To
be more specific, cancer cells are able to proceed twice as fast as normal cells during
the cell cycle in a given environment (see table 1). Naturally, the cell cycle speed
depends on the local oxygen concentration [O2](Xp(t), t) as observed by the cell while
evolving through the cycle. The higher the oxygen concentration, the faster the cycle
is completed, while the cell cycle is put on hold when the cell suffers from hypoxia.
A more detailed biological motivation for this model can be found in [44, 62] and its
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supplementary material. Note that in the cellular automaton model by Owen et al.
(see [44]), all cells can divide an unlimited number of times, which is obviously not a
realistic assumption. Thus, we have extended the model to account for the fact that
cells are only able to divide a finite number of times (i.e. ζp,max). To be more specific
we added a factor H(ζp,max − ζp(t)) to check for the generation of the corresponding
cells. Here, we assume that normal cells can divide only 4 times, which is consistent
with [23]. On the other hand we assume that all the cancer cells are cancer stem cells,
which is still a simplification.
If, for the cell with index i⋆ in population p at time t = t⋆, we obtain Φi⋆,p(t
⋆) ≥ 1
and ζi⋆,p(t
⋆) ≤ ζmax, we introduce a new cell in the simulation. We adjust Ip(t)
according to equation (1) and set Φi⋆,p(t) = 0. and the generation of the parent cell
increases by one. The new cell inherits the state from the cell that divides except for
the generation ζ:
(8)
XIp(t),p(t
⋆) = Xi⋆,p(t
⋆),
[p53]Ip(t),p(t
⋆) = [p53]i⋆,p(t
⋆),
ΦIp(t),p(t
⋆) = Φi⋆,p(t
⋆),
ZIp(t),p(t
⋆) = Zi⋆,p(t
⋆),
[VEGFint]Ip(t),p(t
⋆) = [VEGFint]i⋆,p(t
⋆),
ζIp(t),p(t
⋆) = 0.
Intracellular model. We introduce a intracellular module consistent with [44] in
order to describe some important intracellular concentrations, namely the p53 con-
centration [p53] and the intracellular VEGF concentration [VEGFint]. We have:
(9)
d[p53]p(t)
dt
= c1 − c2
[O2](Xp(t), t)
Cp53 + [O2](Xp(t), t)
[p53]p(t),
d[VEGFint]p(t)
dt
= c3 − c4
[p53]p(t)[VEGFint]p(t)
J5 + [VEGFint]p(t)
,
− c5
[O2](Xp(t), t)
CVEGF + [O2](Xp(t), t)
[VEGFint]p(t).
Cells are storing VEGF intracellular (i.e. [VEGFint]) during hypoxic conditions and
release it once this intracellular concentration has reached a certain threshold level
[VEGFint]thr. Further, c1, . . . c5 and Cp53, CVEGF are constants that can be found
in table 1. Next we describe the model for apoptosis, depending on the cell type.
Therefore we formally define γapt,p(z, np) = Fp(z, np) as the apoptosis rate, which is
further specified in the following paragraphs.
Apoptosis for normal cells. Cell death can be modeled in many ways [52, 24, 6, 56].
Our approach is based on the work of Owen et al. [44]. For normal cells, cell death is
completely determined by the intracellular p53-concentration. So, we set the apoptosis
variable z := [p53]. The apoptosis threshold γapt,1(z, n1) can then be written as:
(10) γapt,1(z, n1) = H

z − zlowH(nthr − n1)︸ ︷︷ ︸
Harsh environment
− zhighH(n1 − nthr)︸ ︷︷ ︸
Normal environment

 ,
where H indicates the Heaviside function. This definition of γapt,1 implies that normal
cells undergo apoptosis if γapt,1(z, n1) = 1 corresponding to the situation that z has
reached a certain threshold value depending on the harshness of the environment.
The threshold value is lower in case of a harsh environment, defined as n1 < nthr,
where nthr denotes a threshold value for the normal cells.
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Apoptosis for cancer cells. In contrast to normal cells, the apoptosis mechanism
for tumor cells is independent of the p53-concentration since this mechanism to reg-
ulate the normal cell cycle, is assumed to be malfunctioning as is the case in many
tumors [2, 30, 65]. The cancer cells in our model are able to go into a quiescent
state when expressed to hypoxic circumstances, meaning that they don’t consume
any nutrients anymore for a while. However the duration of this quiescent state is
limited, which implies that cancer cells will also undergo apoptosis when the hypoxia
holds too long. On the other hand, cancer cells have the ability to recover quickly
once there is again more oxygen available. This mechanism can be modeled by the
following equation:
dZ(t)
dt
= AH([O2]thr − [O2](Xp(t), t))︸ ︷︷ ︸
Linear increase during hypoxia
− BZ(t)H([O2](Xp(t), t) − [O2]thr)︸ ︷︷ ︸
Exponential decay if [O2](Xp(t),t)>[O2]thr
,
where A,B are constants. The first term models the hypoxic state, i.e. the local
oxygen concentration [O2](Xp(t), t) drops below the threshold level [O2]thr. During
this hypoxic period, the internal variable z increases steadily. On the other hand,
the second term describes the recovery of the cancer cells if the environment is not
hypoxic anymore, which is captured by the exponential decay term of Z(t). Cancer
cells die if Z(t) ≥ 1, corresponding to γapt,2(z) = H(z − 1).
Endothelial cells. Note that the model equations concerning cell division and cell
death will not be used for endothelial cells. Consistent with existing literature, the
so-called snail-trail approach is used to model sprouting angiogenesis [7, 32].
Full agent-based model. This results in the following set of equations for the full
agent-based model:
(11)

dXp(t) = χp∇[VEGF](Xp(t), t))
(
1−
np(Xp(t), t)
nmax,p
)
dt+
√
2DpdWt,
dΦp(t)
dt
=
[O2](Xp(t), t)
τmin,p(Cφ,p + [O2](Xp(t), t))
H (ζp(t)− ζp,max) ,
d[p53]p(t)
dt
= c1 − c2
[O2](Xp(t), t)
Cp53 + [O2](Xp(t), t)
[p53]p(t),
d[VEGFint]p(t)
dt
= c3 − c4
[p53]p(t)[VEGFint]p(t)
J5 + [VEGFint]p(t)
+ c5
[O2](Xp(t), t)
CVEGF + [O2](Xp(t), t)
[VEGFint]p(t),
dZ1
dt
=
d[p53]
dt
dZ2
dt
= AH([O2]thr − [O2](Xp(t), t))−BZ(t)H([O2](Xp(t), t) − [O2]thr)
γapt,p(z, np, t) = Fp(z, np, t).
Based on the supplementary material [44], we choose the parameter values as in
table 1.
2.2. Mean-field description. An alternative approach to model tumor growth
is to describe the evolution of the cell densities using partial differential equations
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Parameter n1 n2 n3 units
χp 0.0 0.0 2× 10
−4 cm2/min/nM
ζp,max 4 ∞ 4 times
Cφ,p 3 1.4 mmHg
CVEGF 0.01 0.01 0.01 mmHg
Cp53 0.01 0.01 0.01 mmHg
τp,min 3000 1600 min
zhigh 0.8 dimensionless
zlow 0.08 dimensionless
nthr 0.75 dimensionless
[O2]thr 8.9 mmHg
[VEGFint]thr 0.27 0.27 nM
c1 2× 10
−3 2× 10−3 min−1
c2 1× 10
−2 1× 10−2 min−1
c3 2× 10
−3 2× 10−3 min−1
c4 2× 10
−3 2× 10−3 min−1
c5 1× 10
−2 1× 10−2 min−1
J5 0.04 0.04 nM
A 1 min−1
B 2.5× 10−3 min−1
Table 1
Parameter values related to the populations, chosen in agreement with [44].
(PDEs). In general, this approach yields a reaction-diffusion PDE of the following
form:
(12)
∂tnp(x, t) = Dp∇
2np(x, t)− χp∇ ·
[
np(x, t)
(
1−
np(x, t)
np,max
)
∇[VEGF](x, t)
]
+R(x.t),
where the reaction term R(x, t) accounts for the (dis)appearance of cells (i.e., cell di-
vision and apoptosis). A closed (mean-field) model would require one to write R(x, t)
in terms of the densities np(x, t). However, in this case, obtaining such a closed for-
mulation is not possible, since cell division and apoptosis depends on intracellular
processes. Nevertheless, formally, a simulation of a large number of cells, using the
agent-based model outlined in section 2.1, can be seen as a particle-based discretiza-
tion of the above mean-field PDE, even if it is not available in closed form.
When one ignores births and deaths, obtaining a closed model at the level of cell
densities is possible, see [33]. The resulting macroscopic equation for the evolution of
the populations is of advection-diffusion type and reads:
(13) ∂tnp(x, t) = Dp∇
2np(x, t) − χp∇ ·
[
np(x, t)
(
1−
np(x, t)
np,max
)
∇[VEGF](x, t)
]
,
and is obtained by taking the limit of the number of cells going to infinity.
From now on, we will consider the agent-based model of section 2.1 as a stochastic
particle discretization of the mean-field model (12) that is not available in closed form.
We will therefore interchangeably use the terms “particle” and “cells” in the remainder
of the manuscript when we denote instances of the stochastic process outlined in
section 2.1.
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Finally, we also introduce the following discretization of the advection-diffusion
PDE (13):
(14)
np(x, t
k+1) = np(x, t
k) + δtDp∇
2np(x, t
k)
− δt
(
χp∇.
[
np(x, t
k)
(
1−
np(x, t
k))
np,max
)
∇[VEGF](x, tk)
])
,
in which δt denotes the time-step and we have used a first order Euler discretization
to discretize the time derivative and a second order central finite volume scheme to
discretize the spatial derivatives. Further details can be found in section 4.
2.3. Angiogenesis. The growth of new blood vessels, also known as angiogen-
esis, is essential for the further development of a tumor. Hanahan and co-authors
identified it as one of the hallmarks of cancer (see [30, 29]). For a general review
about angiogenesis, we refer to the work of Carmeliet et al. [12]; specifically for tumor
angiogenesis, we mention [40, 14]. In the early stages of cancer, the existing vascula-
ture is able to provide a sufficient amount of oxygen and other nutrients. However,
as soon as the size of the tumor has reached a certain threshold, a hypoxic zone de-
velops in the middle of the tumor [39, 55]. To cope with this phenomenon, the tumor
secretes VEGF, a growth factor, which triggers endothelial cells to move chemotacti-
cally towards this hypoxic zone and grow new blood vessels. In this paper we will use
an existing model for angiogenesis, described in [44]. We distinguish two phenotypes:
endothelial cells can either be motile leader cells (also called tip cells) or static stalk
cells. We model proliferation of endothelial cells by means of the so-called snail-trail
approach, where each tip cell produces a new (static) endothelial cell at its previous
position, creating a trail of static stalk cells behind him. Apart from this feature, new
tip cells –known as sprouts– can emerge from active vessels with sprouting probability
Psprout along the active vessels. (see [44]):
(15) Psprout = δt
Pmax[VEGF](x, t)
Vsprout + [VEGF](x, t)
where Pmax = 3× 10
−4 min−1 indicates the maximal endothelial sprouting rate
( see [44]) and Vsprout = 0.5 nM denotes the VEGF concentration at which the
sprouting probability is half maximal. Note that the probability of the emergence
of two sprouts close to each other within the same time-step is zero. A biological
explanation for this fact can be found in the supplementary material provided with
[44] and [27, 7, 35], where the authors pointed out that delta-notch signaling inhibits
the formation of new sprouts in neighboring endothelial cells. Additionally, the vessel
radii are also adapted dynamically based on the work of [44] where pruning of the
vessels was also incorporated in the model: if the pressure in a branch is too low, the
corresponding branch will collapse.
2.4. Environment. We model the cellular environment by means of two dif-
fusible components regulating the behavior of the cells in various ways. Oxygen is
evidently important for the cells to proceed through the cell cycle [36, 44, 48, 1, 45].
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The local oxygen concentration is determined from the following equation:
(16)
∂t[O2](x, t) = D[O2]∇
2[O2](x, t)︸ ︷︷ ︸
diffusion
+ψ[O2]nv(x, t)([O2]blood − [O2](x, t))︸ ︷︷ ︸
exchange with blood
+ [O2](x, t)k[O2 ]
P∑
p=1
np(x, t)
︸ ︷︷ ︸
Consumption
,
where D[O2] is the diffusion coefficient of oxygen, ψ[O2] denotes the permeability of the
oxygen through the vessels. nv(x, t) describes the surface area occupied by the vessel
at position x. [O2]blood(x, t) = [O2]refH(x, t)/Hin defines the oxygen concentration
in a blood vessel located at position x. [O2]ref is a reference oxygen concentration,
H(x, t) is the haematocrit at location x and time t and Hin is the haematocrit at an
inflow node. In agreement with [44], we set this value by default to Hin = 0.45. The
last term in (16) reflects the fact that all cells consume oxygen at a rate k[O2].
A similar approach is used to describe the local concentration of growth factors
(e.g., Vascular Endothelial Growth Factors) denoted by [VEGF]. VEGF plays a cru-
cial role in vascular tumor growth, since it triggers angiogenesis. Hence, it is usually
taken into account in recent tumor growth modeling [10, 53]. The corresponding
reaction-diffusion equation for VEGF reads:
(17)
∂t[VEGF](x, t) = DVEGF∇
2[VEGF](x, t)︸ ︷︷ ︸
diffusion
−ψVEGFnv(x, t)[VEGF](x, t)︸ ︷︷ ︸
exchange with blood
+SVEGF(x, t)︸ ︷︷ ︸
production
,
− δVEGFVEGF(x, t)︸ ︷︷ ︸
decay
S[VEGF](x, t) = k[VEGF]
P∑
p=1
Ip(t)∑
i=1
δXi,p(t)H([VEGFint]i,p(t)− [VEGFint]thr).
Parameter Oxygen VEGF units
D 0.0014 6× 10−4 cm2/min
ψ 6 6× 10−4 cm/min
δ 0 0.6 min−1
k[O2] −13 min
−1
k[VEGF] 0.6 min
−1
[O2]ref 20 mmHg
Table 2
Parameter values of the reaction diffusion equations.
3. Variance reduction. In this section, we propose an algorithm to reduce the
variance on the cell densities np(x, t) obtained from the agent-based simulation. The
algorithm relies on the combination of three simulations: (i) a stochastic simulation
with the full microscopic model; (ii) a coupled stochastic simulation with an approxi-
mate, coarse agent-based model; and (iii) a deterministic grid-based simulation of the
same coarse model. The full microscopic model uses an ensemble of Ip(t) particles
with state variables:
(18) {Xi,p(t), Zi,p(t),Φi,p(t), ζi,p(t), [p53]i,p(t), [VEGFint]i,p(t)}
Ip(t)
i=1 .
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As the coarse agent-based model, we conceptually consider an agent-based model in
which the internal state has been suppressed and only the position remains:
(19) {Xci,p(t)}
Ip(t)
i=1 .
So, no internal dynamics is present in the coarse model: cells cannot divide, die or
secrete VEGF. (In practice, we will not perform a separate simulation for the coarse
model, but instead use the results obtained from the complete agent-based model,
in which we neglect the effects of apoptosis and cell division). The only dynamics
remaining then is motion, which can be modeled with a PDE for the population
density (see equation (13)). We call this coarse approximation the control process.
We also introduce the formal semi-group notation:
(20)
etL
c
p(n
c
p) with Lcp(n
c
p) = −Dp∇
2 −χp∇ ·
[
np(x, t)
(
1−
np(x, t)
np,max
∇[VEGF](x, t)
)]
,
that represents the exact solution of the macroscopic partial differential equation (13).
In practice, the solution will be approximated by a deterministic solution on a grid.
It should be clear that the advection-diffusion behavior in both agent-based models is
identical. Thus, the only difference between the two models occurs when cells divide
or die. Assuming no reactions take place, the three processes thus have the same
expectation. This observation leads to the following variance reduction algorithm.
As an initial condition, we start from Ip(0) particles representing the number density
np(x, 0). For each particle, we choose a given internal state, for instance Φi,p(0) =
Zi,p(0) = 0, ζi,p(0) = 0, [p53]i,p(0) = 0, [VEGFint]i,p(0) = 0, 1 ≤ i ≤ Ip(0), 1 ≤
p ≤ P . (These internal states could also be sampled from an appropriate probability
distribution.) Additionally, we introduce the variance reduced measure n¯p(x, t), which
we initialize as n¯p(x, 0) = np(x, 0). We denote the time step δt and the discrete time
instances tℓ = ℓδt, ℓ ≥ 0.
Algorithm 1 (Variance reduction for tumor growth). We advance the variance
reduced number density n¯(x, t) from time tℓ to tℓ+1 as follows:
• Evolve the particle states (18) from tℓ to tℓ+1 using the agent-based model
(11).
• Compute the number density for the stochastic microscopic model using (4),
as well as the number density for the coarse process as
(21) ncp(x, t
ℓ+1) =
Ip(t
ℓ)∑
i=1
wi,p(t
ℓ)δXi,p(tℓ+1),
i.e., we compute the number density for the control process based on particle
positions and velocities at time tℓ+1, taking into account only the particles
that were present in the simulation at time tℓ.
• Evolve the control number density ncp(x, t) using a grid-based method based
on (13) and add the reactions (the difference in number density due to cell
division and apoptosis)
(22) n¯p(x, t
ℓ+1) := n¯p(x, t
ℓ) eδtL
c
+ np(x, t
ℓ+1)− ncp(x, t
ℓ+1).
This procedure will be repeated after reinitializing the control density n˜p(x, t) =
n¯p(x, t). Reinitialization guarantees that these differences between the full and the
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coarse model do not accumulate over time. The importance of reinitialization can
be illustrated by looking into the following hypothetical situation. Suppose the ith
cell of type p divides at time t = t⋆, and hence cell Ip + 1 is born. At time t > t
⋆,
this newborn cell has moved randomly through the domain. Apart from this random
motion, it also has influenced the environment along its track.
The algorithm can alternatively be written in terms of the reaction field:
Definition 2 (Reaction field). The control process differs from the full micro-
scopic model in the way that there are no births, deaths or VEGF-secretion events.
The direct influence on the population density can be summarized by the reaction field
defined as:
(23)
Rp(x, t
l+1) = np(x, t
l+1)− ncp(x, t
l+1)
=
Ip(t
l+1)∑
i=1
wi,p(t
l+1)δXi,p(tl+1) −
Ip(t
l)∑
i=1
wi,p(t
l)δXi,p(tl+1).
We also introduce a shorthand notation:
Definition 3 (Deterministic control density). Denote the control density calcu-
lated with the macroscopic evolution equation as:
(24) n˜p(x, t
l+1) := n¯p(x, t)e
δtLc .
To see that the proposed estimator for the population densities np is unbiased
and that the algorithm indeed reduces the variance on the cell densities, we have the
following theorem:
Theorem 4 (Unbiased estimator). Assume that discretization errors are absent.
Then, the algorithm described above yields an unbiased estimator for the population
density np.
Proof. Assume that discretization errors are absent. Then, we can calculate the
expectation value of n¯p based on equation (22) as follows:
E
[
n¯p(x, t
l+1)
]
= E
[
n˜p(x, t
l+1)
]
+ E
[
np(x, t
l+1)
]
− E
[
ncp(x, t
l+1)
]
,
where E(np(x, t)) denotes the expectation value of the quantity np(x, t). By using
sequentially the definition of n˜cp (see equation (24)) and the linearity of E, we can
conclude that E[n¯p] = E[n˜p] and hence n¯p is indeed an unbiased estimator.
Note that the algorithm described above is similar to the technique used in [51]
to simulate bacterial chemotaxis. The main differences are due to the fact that (i) the
model is not conservative; and (ii) the internal dynamics only relates to cell division,
apoptosis and VEGF secretion and not to advection-diffusive behavior.
4. Results. In this section, we will illustrate the performance of the variance
algorithm described above with various numerical experiments. The cells are living
on a 50× 50 square grid. By default 2000 normal cells are uniformly distributed over
the whole domain. A small tumor consisting of 200 cancer cells are initially normally
distributed with mean 0.25∆x and standard deviation 0.05∆x closely to the left vessel.
We simulate the system over 1920 time-steps (or 40 days). The whole set of default
parameters is summarized in table 3. To initialize the agent-based simulation, we
sampled Ip(0) particles from the corresponding distribution. As pointed out before,
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we are mainly interested in the evolution of a probability distribution. Hence, the
equation to calculate the cell number density can be rewritten as:
(25) np(x, t) =
Ip(t)∑
i=1
qi,pwi,p(t)δXi,p(t),
where an additional weight qi,p is attached to each particle. This implies that each
particle has a lower mass. The total mass is
∑Ip(t)
i=1 qi,pwi,p(t). During the numerical
experiments, we will use weights qp independent of both the specific i-th particle of
population p and of the time.
Further, we initialize the environment as follows: two straight vessels at x = 20∆x
and x = 40∆x, corresponding to a moderate vascular density of 50 cm2/cm3 (see [44]).
The latter results in average oxygen concentrations, in the sense that cells are pro-
ceeding through the cell cycle at a speed, which is approximately half maximal. More
details concerning realistic vascular densities and oxygen concentrations can be found
in the supplementary material provided with [44].
The macroscopic equations are simulated using a simple Euler discretization for the
time derivative and a second order central finite volume to discretize the spatial deriva-
tive. In the first three experiments, we have chosen for an explicit method. Further,
the linear systems originating from the reaction-diffusion PDEs modeling the envi-
ronment are solved using a conjugate gradient algorithm ( [28]). The default choice
of discretization, time-step and number of cells can be found in table 3.
The discussions corresponding to each of the individual experiments are organized as
follows. First we consider the evolution of the population densities and the environ-
ment. Afterwards, we take a closer look at the variance with and without variance
reduction. The results of the experiments are obtained by averaging out over 100
realizations.
Remark 1 (Color code). During the numerical experiments, we adopt the fol-
lowing color code to describe the different quantities. A colormap from white (low)
towards gray (high) is used for the mean population densities (both normal and cancer)
and the variance on the corresponding densities.
Remark 2 (units). We use minutes as default time unit and cm as the spatial
unit. Those will be omitted in the figure titles for compactness.
Parameter Normal Cancer EC units
Dp 0 5× 10
−9 1× 10−8 cm2/min
Ip(0) 2000 200 0 #particles
qi,p 1 0.5 1 dimensionless
δt 30 30 30 min
np,max 1 2 2 #particles
∆x 4× 10−3 4× 10−3 4× 10−3 cm
a 0.5∆x 0.25∆x cm
b 0.5∆x 0.05∆x cm
Table 3
Default parameter set used for the numerical experiments
4.1. A small-scale experiment with a static vasculature. In figure 2, we
have plotted the population density of the normal and cancer tissue, along with the
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oxygen concentration at time t = 5.76× 104 min. The tumor immediately influences
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Fig. 2. Mean cellular densities –normal tissue: (left panel), cancer cell density: (mid-
dle panel)– and mean oxygen concentration (right panel) calculated using variance reduction at
time t = 5.76× 104 min.
the normal tissue in the sense that a significant amount of normal cells die in this
cancerous region. They literally have to make place for the growing tumor. Apart from
apoptosis due to competition from cancer cells, cells also die due to lack off oxygen in
between the two existing vessels. In the meantime, the tumor grows along the vessel
until the tissue is locally saturated, meaning that
∑
p∈{p=1,...P} np(x, t) > np,max.
The high birth rate can be explained by the high oxygen concentration. Furthermore,
the cells also diffuse in the other directions due to the random Brownian motion. This
evolution can also be seen as an illustration of the “go or grow”-paradigm, which is
identified as an important characteristic of the aggressiveness of the tumor [31, 25].
This process continues until the tissue is fully saturated along the leftmost vessel.
Note that none of the cells is able to cross the low oxygen zone. They would all die
due to the hypoxic environment.
We investigate how the population densities shown in figure 2 influence the variance.
Figure 3 illustrates the elements contributing to the variance (see equation (28)). We
first consider the variance with and without reduction in more detail. Combining the
definitions of both variance and np, n¯p yields:
Var[np(x, t)] = Var[n
c
p(x, t) +Rp(x, t)],(26)
= Var[ncp(x, t) + Var[Rp(x, t)] + 2Cov(n
c
p(x, t), Rp(x, t)),(27)
Var[n¯p(x, t)] = Var[n˜
c
p(x, t)] + Var[Rp(x, t)] + 2Cov(n˜
c
p(x, t), Rp(x, t)),(28)
the variance on the reaction field (left), the variance on the corresponding control den-
sities – without variance reduction nc2 and with variance reduction n˜
c
2 – (middle) and
the covariance between the reactions and the control densities (right). We compare
the results without (first row) and with variance reduction (second row).
The variance on the reaction field is stretched along the leftmost vessel, as is the
tumor itself. To explain the pattern in more detail, we have to compare the vari-
ance on the reaction field with the corresponding density. The variance is especially
high just next to the largest concentration of the tumor, where the concentration of
reactions is high due to the combined effect of the relatively high number of cancer
cells and the fact the tissue is not fully saturated yet. Note that the variance on the
reaction field does not depend on the variance reduction, since it is fully determined
by the results of the agent-based simulation.
However, the image is completely different for the variance on the corresponding con-
trol densities. Observing the middle picture on the first row leads to the conclusion
that the noise is dominated by random motion since the variance is larger in the
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middle of the tumor than at the border where most of the reactions take place. In
contrast, after applying variance reduction the variance is fully determined by the
reactions, implying that the variance is mostly filtered by the algorithm.
The above analysis (see figure 3) of the evolution of the variance clearly demonstrates
the strong correlation between the oxygen concentration and the variance on the pop-
ulation densities. A more detailed view of the evolution can be found in the supple-
mentary material (see section 6.2 for further details). To illustrate the performance of
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Fig. 3. Evolution of the factors contributing – Var(R2(x, t)) (left), Var(nc2(x, t)) (middle) and
Covar((R2, nc2)(x, t)) (right) – to variance on mean cancer cell density with (second row per time)
and without variance reduction at time t = 5.76× 104 min.
the algorithm in another way, we have taken some slices – at y = 0.04 cm, y = 0.1 cm
and y = 0.14 cm respectively – of the cancer cell density at t = 5.76× 104 min. In
figure 4 they are plotted along with their 95% confidence interval. The results based
on the full stochastic model are plotted in black, while the results using the variance
reduction algorithm are colored in gray. It can easily be seen that there is indeed
a significant reduction and that the results using the variance reduction algorithm
are consistent with the original results in the sense that they closely approximate the
solution from the full stochastic model and that the variance is reduced significantly.
4.2. Experiment on a larger domain. As pointed out before, our lattice-
free approach allows to rescale the system in a straightforward way. Since the cost
mainly depends on the number of particles and only marginal on the the domain
size, it is possible to consider to perform a similar experiment on a rescaled (coarser)
grid. To illustrate this we perform the simulation with ∆x = ∆y = 1.26× 10−2 cm,
corresponding to a domain of 0.4cm2, corresponding with an upscaling of a factor
10. The normal tissue initially consists of 2× 104 particles and a tumor of 1000 cells.
According to the rescaled domain the maximal number of cells per volume was also
scaled with a factor 10. In figure 5 we have plotted the evolution of the cellular
distributions of the different cell types and the corresponding oxygen concentration.
From the plot in the left column, one can see that normal cells are multiplying along
the rightmost vessel since the left vessel is fully occupied by the tumor and there is
not enough space for both the tumor and normal cells. In the rest of the domain the
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Fig. 4. Mean cancer cell density and corresponding 95% confidence interval at time t =
5.76× 104min at y = 0.04 cm (left), y = 0.1 cm (middle) and y = 0.14 cm (gray) with (black)
and without variance reduction (red).
normal tissue is reduced to a minimal level due to lack of oxygen and the influence of
the tumor.
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Fig. 5. Mean population densities and oxygen distribution in a large scale setting at time
t = 5.76× 105 min.
In figure 6, we examine the influence of the variance reduction algorithm on the
variance on the resulting tumor cell density as a function of time. Comparing the
variance plot with (right panel) and without (left panel) give rise to the observation
that the algorithm again yields a reduction of the variance both in the center and at
the border of the tumor. This implies that the border of the tumor can be estimated
in a more accurate, which determines the harshness of the tumor.
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Fig. 6. Evolution of the variance on the mean cancer cell density in a large-scale setting with
and without variance reduction at time t = 5.76× 105 min, zoomed in on the left vessel.
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4.3. Variance reduction for sprouting angiogenesis. As a last experiment
we will examine the performance of the algorithm in the case where the vasculature
is also updated dynamically according to the model outlined in the section 2. A
small tumor mass of initially 100 cells - sampled from a uniform distribution, with
parameters a2 = 0.3∆x, b2 = 0.1∆x. The population density is discretized with
200 cells, i.e. qi,2 = 0.5. Further, we have chosen D2 = 1× 10
−8cm2/min. The
other parameters are set to the default values outlined in table 3. In contrast to
the previous experiments, the cancer cells are now able to cause extension of the
vascular network according to their needs. The resulting oxygen distribution reveals
a strong correlation with the cancer cell distribution itself, meaning that the tumor
is fully vascularized now and can grow further. A small fraction of the tumor even
managed to reach the second vessel supported by some new branches in the vascular
network created in response to the high VEGF gradients. Next, we investigate how the
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Fig. 7. Mean cellular densities and oxygen distribution at time t = 5.76× 104 min with dy-
namical vasculature
variance reduction algorithm is performing in this setting of dynamic vascularization.
In figure 8, we have plotted the variance on the mean cancer cell density with (n¯2(x, t))
variance reduction on the right and and without variance reduction on the left.
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Fig. 8. Variance with and without variance reduction on the mean cancer cell density with a
dynamic vasculature at time t = 5.76× 104 min
A comparison of the two variance plots in figure 8 leads to the conclusion that
the variance is reduced everywhere. Along the leftmost vessel, the algorithm was even
able to eliminate the noise completely. Indeed, the tissue is saturated here, so no new
cells are born here. Besides, there is enough oxygen available to avoid apoptosis. Just
outside this zone of maximal saturation the tissue is not so dense giving rise to more
births and a higher level of noise here. In this region, the noise is proportional to the
local density itself.
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4.4. Fast diffusing cancer cells. Motivated by the hypothesis that the diffu-
sion coefficient can be related to the aggressiveness of the tumor, we investigate the
situation where cancer cells have a higher diffusion coefficient. Swanson et al. have
shown [60] that glioma’s with a higher diffusion coefficient have a higher probabil-
ity to cause metastases, which is obviously an important characteristic for the long-
term survival probability of the patient. Apart from the modified diffusion coefficient
D2 = 5× 10
−7 cm2/min, we adopt the same initial configuration as in the previ-
ous experiment. Note that the simulations are performed with a smaller time-step
(δt = 0.3 min) in order to fulfill the CFL-condition corresponding to the macroscopic
equation.
In figure 9, the evolution of both the normal tissue and the tumor are shown along
with the local oxygen concentration at t = 1.152× 103 min. As in the previous ex-
periment, the normal tissue density is the result of the cell deaths due to the presence
of the tumor, while the normal cells are more sensitive to hypoxic environment. The
tumor, on the other hand, has diffused through the normal tissue significantly on this
short timescale, without consuming too much oxygen. Indeed, the cancer cells have
already covered a large distance within a rather short time interval, meaning that
the tumor exhibits the go-phenotype, rather than the grow -phenotype as it was the
case in the first experiment. As can be observed from the leftmost picture in figure 9,
only a relatively small fraction of the normal cells died. However, this scenario is
potentially dangerous since it can stay more or less invisible for a long time and as
soon as the tumor reaches a vessel it is possible that cells invade a vessel and give rise
to metastatic spread of the cancer.
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Fig. 9. Evolution of the cellular populations as a function of time (at time t = 1.52 × 103 min,
with fast diffusing cancer cells.
As before, we also examine the variance on the mean cancer cell density with
and without variance reduction. Without variance reduction, the resulting variance
is proportional to the density itself, suggesting that the variance is mainly caused
by the random jumps. Obviously, the latter will be higher in zones with more cells.
When variance reduction is applied, the variance is reduced with at least a factor 100
point-wise and moreover the plot reveals a clear pattern, which is again related to the
oxygen concentration.
5. Discussion. We developed a novel variance reduction technique specifically
suited to reduce the noise of agent-based models with birth and death events, as it is
the case in our model for tumor growth. We proved that the algorithm outlined in
section 3 gives rise to an unbiased estimator and the variance is determined by the
births and deaths. The performance was illustrated numerically in different possible
regimes characterizing different aspects of tumor growth such as sprouting angiogen-
esis, highly diffusive cancer cells and large-scale systems. The proposed algorithm
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Fig. 10. Evolution of the variance on the mean cancer cell density with and without variance
reduction at time t = 1.152× 103 min.
is based on the idea of control variates, since the evolution of the system without
reactions is known deterministically via the macroscopic equation (13).
A valuable extension would be to combine this algorithm with other variance reduc-
tion techniques such as importance sampling. It is self-evident that an accurate and
efficient simulation of all the different aspects of the system is crucially important for
the reliability of the system as a whole. Apart from that, we will also extend our
model with important features such as haptotaxis in response to the extra-cellular
matrix and include a more sophisticated model for stemcellness [15, 41, 16] since it
was identified as one of the hallmarks of cancer [30]. Another track worthwhile further
investigation is to apply our technique to patient-specific data. For instance, patient-
specific data, like MRI-images or blood parameters, could be used as a specific initial
configuration [39]. Finally, this algorithm can also be applied on related systems such
as bone fracture healing and other application where we are interested in macroscopic
behavior, but with agent-based features characterizing the dynamics.
6. Supplementary material.
6.1. Video 1. Evolution of the population densities in the small scale
setting. Evolution of the mean normal and cancer cell density from time t = 0
till time t = 5.76× 104 min. The initial configuration corresponds with the first
numerical experiment. For the oxygen concentration we adopted a colormap with a
range from white (low concentrations) towards black (high concentrations).
6.2. Video 2. Evolution of the variance in the small scale setting. Evo-
lution of the variance on the mean normal and cancer cell density from time t = 0 till
time t = 5.76× 104 min. We again adopted a colormap with a range from white (low
variance) towards black (high variance levels).
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